-- How Should We Respond to MRSA?: Loren Miller, MD, MPH, director of the
Infection Control Program at Harbor-UCLA, associate professor of
medicine at the David Geffen School of Medicine at the University of
California, Los Angeles and faculty member in the division of Adult
Infectious Diseases at Harbor-UCLA Medical Center, discussed methods to
control and prevent MRSA infections. Methicillin-resistant
Staphylococcus aureus (MRSA) infections have become increasingly common
in the past few years. MRSA poses risk for infection within and outside
healthcare settings. MRSA are a type of Staphylococcus aureus
bacteria, commonly known as "Staph" that are resistant to many commonly
used antibiotics. "There is no simple magic bullet to respond to MRSA.
Efforts to prevent MRSA need to be multi-faceted and coordinated,"
stated Dr. Miller.
-- Childhood and Adolescent Vaccines: More Important than Ever: Larry K.
Pickering, MD, FAAP, senior advisor to the director of the National
Center for Immunization and Respiratory Diseases of the Centers for
Disease Control and Prevention, executive secretary of the Advisory
Committee on Immunization Practices (ACIP) and professor of pediatrics
in the department of pediatrics at Emory University School of Medicine
outlined the successes achieved by the immunization program; the
importance and benefits of childhood, adolescent and adult immunization
platforms; the effects of an unvaccinated population; and future
advances to further improved health. "Today, recommended vaccines are
available to prevent 16 infectious diseases as well as two forms of
cancer. As future vaccines become available to prevent other infectious
diseases, cancers, and other conditions, funding mechanisms must be
protected and publ
|SOURCE National Foundation for Infectious Diseases|
Copyright©2008 PR Newswire.
All rights reserved